Journal of Acupuncture Research

  • 제41권2호
  • /
  • Pages.107-114
  • /
  • 2024
  • /
  • 2586-288X(pISSN)
  • /
  • 2586-2898(eISSN)
대한침구의학회 (Korean Acupuncture & Moxibustion Medicine Society)
권호 표지
DOI QR코드

DOI QR Code

Effectiveness and Safety of Pharmacopuncture Therapy for Chronic Low Back Pain: A Study Protocol for a Pragmatic Randomized Controlled Trial

  • Youn Young Choi (Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Daejeon University) ;
  • Hwa Yeon Ryu (Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Daejeon University) ;
  • Jae Hui Kang (Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Daejeon University) ;
  • Hyun Lee (Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Daejeon University)
  • 투고 : 2024.04.12
  • 심사 : 2024.05.03
  • 발행 : 2024.05.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Low back pain (LBP) is a common musculoskeletal disorder worldwide, with a lifetime prevalence of up to 80%. Among nonsurgical treatments for chronic LBP, Korean medicine treatments are highly preferred, and pharmacopuncture therapy combining acupuncture and herbal medicine is widely used. However, no evidence-based study has focused on the use of various types of pharmacopuncture. Methods: The pragmatic randomized controlled clinical trial will include 44 participants; recruitment will start in July 2023. All participants will receive integrated Korean medicine treatment including acupuncture, cupping, and infrared therapy, and the intervention group will also receive pharmacopuncture. After 16 treatment sessions, twice a week for 8 weeks, follow-up assessments will be performed at week 9. As a pragmatic randomized controlled clinical protocol, the type, dose, and acupoints of acupuncture and pharmacopuncture are not determined in advance but are selected and recorded according to the clinical judgment of the Korean medicine doctor. Results: The primary outcome will be measured using a visual analog scale score, and the secondary outcomes include the Oswestry disability index, patient global impression of change, no worse than mild pain, and range of motion. Safety will be assessed by examining participants' self-reported adverse events and vital signs and conducting blood tests before and after the test. Conclusion: This study aims to provide clinical evidence of the effectiveness and safety of pharmacopuncture for chronic LBP.

키워드

과제정보

We would like to thank Daejeon University Research Grants (2023) for supporting study.

참고문헌

  1. Hartvigsen J, Hancock MJ, Kongsted A, Louw Q, Ferreira ML, Genevay S, et al. What low back pain is and why we need to pay attention. Lancet 2018;391:2356-2367. doi: 10.1016/S0140-6736(18)30480-X
  2. Hoy D, Bain C, Williams G, March L, Brooks P, Blyth F, et al. A systematic review of the global prevalence of low back pain. Arthritis Rheum 2012;64:2028-2037. doi: 10.1002/art.34347
  3. Andersson GB. Epidemiological features of chronic low-back pain. Lancet 1999;354:581-585. doi: 10.1016/S0140-6736(99)01312-4
  4. Liao J, Wang T, Dong W, Yang J, Zhang J, Li L, et al. Acupoint injection for nonspecific chronic low back pain: a protocol of systematic review. Medicine (Baltimore) 2019;98:e16478. doi: 10.1097/MD.0000000000016478.
  5. Urits I, Burshtein A, Sharma M, Testa L, Gold PA, Orhurhu V, et al. Low back pain, a comprehensive review: pathophysiology, diagnosis, and treatment. Curr Pain Headache Rep 2019;23:23. doi: 10.1007/s11916-019-0757-1
  6. Gore M, Sadosky A, Stacey BR, Tai KS, Leslie D. The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings. Spine (Phila Pa 1976) 2012;37:E668-E677. doi: 10.1097/BRS.0b013e318241e5de
  7. Cheon C. Traditional Korean medicine treatment patterns in patients with low back pain: a cross-sectional study based on the 2017 Korean Medicine Utilization and Herbal Medicine Consumption Survey. Eur J Integr Med 2020;36:101124. doi: 10.1016/j.eujim.2020.101124
  8. Kim JH, Nam DW, Kang JW, Kim EJ, Kim KS, Kang SK, et al. A review of clinical trials for development of assessment criteria for chronic low back pain. J Korean Acupunct Moxib Soc 2009;26:215-224.
  9. Korean Pharmacopuncture Society Academic Committee, Pharmacopuncture Research Institute. Pharmacopuncturology. 2nd ed. Elsevier Korea; 2011;3-12,191-196.
  10. Park KS, Kim S, Seo JY, Cho H, Lee JY, Lee YJ, et al. Effectiveness and safety of pharmacopuncture therapy for chronic low back pain: a protocol for a pragmatic randomized controlled trial. J Pain Res 2022;15:2629-2639. doi: 10.2147/JPR.S375231
  11. Cha HJ, Han CH, Jeon JH, Jeong JK, Kim HK, Yang C, et al. Effectiveness and safety of adjunctive pharmacopuncture to acupuncture treatment for rotator cuff diseases: a protocol for an assessor-blinded, pragmatic randomized controlled, pilot trial. J Acupunct Meridian Stud 2023;16:79-87. doi: 10.51507/j.jams.2023.16.2.79
  12. Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ 2013;346:e7586. doi: 10.1136/bmj.e7586
  13. Park KS, Kim S, Kim C, Seo JY, Cho H, Kim SD, et al. A comparative study of the effectiveness of pharmacopuncture therapy for chronic neck pain: a pragmatic, randomized, controlled trial. J Clin Med 2021;11:12. doi: 10.3390/jcm11010012
  14. Whitehead AL, Julious SA, Cooper CL, Campbell MJ. Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Stat Methods Med Res 2016;25:1057-1073. doi: 10.1177/0962280215588241
  15. Fairbank JC, Pynsent PB. The Oswestry Disability Index. Spine (Phila Pa 1976) 2000;25:2940-2952; discussion 2952. doi: 10.1097/00007632-200011150-00017
  16. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole MR. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001;94:149-158. doi: 10.1016/S0304-3959(01)00349-9
  17. Moore RA, Straube S, Aldington D. Pain measures and cut-offs -'no worse than mild pain' as a simple, universal outcome. Anaesthesia 2013;68:400-412. doi: 10.1111/anae.12148
  18. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis 1967;20:637-648. doi: 10. 1016/0021-9681(67)90041-0 https://doi.org/10.1016/0021-9681(67)90041-0
  19. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Clin Epidemiol 2009;62:499-505. doi: 10.1016/j.jclinepi.2009.01.012
  20. Yun YJ, Kang KW, Choi SM. An analysis of clinical trials for understanding and application of pragmatic clinical trial. J Korean Acupunct Moxib Soc 2009;26:105-116.
  21. Seo BK, Han K, Kwon O, Jo DJ, Lee JH. Efficacy of bee venom acupuncture for chronic low back pain: a randomized, double-blinded, sham-controlled trial. Toxins (Basel) 2017;9:361. doi: 10.3390/toxins9110361
  22. Lee YJ, Shin JS, Lee J, Kim MR, Park KB, Lee HD, et al. Usage report of pharmacopuncture in musculoskeletal patients visiting Korean medicine hospitals and clinics in Korea. BMC Complement Altern Med 2016;16:292. doi: 10.1186/s12906-016-1288-5
  23. Shin BC, Kong JC, Park TY, Yang CY, Kang KW, Choi SM. Bee venom acupuncture for chronic low back pain: a randomised, sham-controlled, triple-blind clinical trial. Eur J Integr Med 2012;4:e271-e280. doi: 10.1016/j.eujim.2012.02.005
  24. Park KS, Kim C, Kim JW, Kim SD, Lee JY, Lee YJ, et al. A pragmatic randomized controlled trial on the effectiveness and safety of pharmacopuncture for chronic lower back pain. J Pain Res 2023;16:2697-2712. doi: 10.2147/JPR.S413512